Inflation and the stock market, the efficacy of the Pfizer/BioNTech's vaccine, UK to speed up vaccines, Bitcoin, Twitter, Uber, Singapore's construction sector, HSBC, Chinese Yuan and the Indian Rupee

Alphabet’s blockbuster quarter puts AI back in the spotlight as the tech giant delivers surging profits and resilient ad growth, even as markets turn jittery. Hosted by Michelle Martin with Ryan Huang...

5 Feb 22min

China’s investment narrative is shifting from old economy giants to new-generation growth engines. Michelle Martin speaks with Dr Wealth cofounder Alvin Chow, to explore whether the new CSI A500 index...

4 Feb 22min

Big Pharma’s report cards just rewrote the market mood. Market View dives into why Pfizer slipped into a quarterly loss, why Novo Nordisk plunged double digits, and how Merck managed to buck the trend...

4 Feb 22min

Danielle Lim, author of The Sound of S-C-H, joins READ with Michelle Martin to discuss the newly reissued edition of her Singapore literature prize-winning book that chronicled her uncle’s life with s...

3 Feb 22min

Money and Me unpacks why global investors may be hedging U.S. exposure rather than fleeing it outright, even as the dollar weakens and trade tensions simmer. Our guest, John Sidawi, Senior Portfolio M...

3 Feb 18min

Disney beats earnings but warns of falling tourist demand, sending its shares sharply lower. Costs are eating into some of the Disney magic. Meanwhile, Elon Musk is building a super stock story. Elon ...

3 Feb 24min

Markets are flashing warning lights - and investors are wondering if the rules have changed. Gold and silver tumble after a near-vertical rally as politics collides with monetary policy. We unpack why...

2 Feb 15min

Big Pharma goes global, precious metals go vertical - then crash, and Wall Street braces for a new Fed era. Market View tracks AstraZeneca’s New York debut and what it signals about the race between t...

2 Feb 24min